FKA‐A NPs enhances PTX‐A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FKA‐A NPs enhances PTX‐A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway

Published:2022-09-07 Issue:1 Volume:37 Page:125-136
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Li Juan¹,Wang Rongmei¹,Liu Yongqing¹^ORCID,Wu Yuqian²,Han Leiqiang¹,Zheng Lei³^ORCID,Bao Zhengqiang²

Affiliation:

1. Department of Clinical Pharmacy, The Second Hospital, Cheeloo College of medicine Shandong University Jinan Shandong China

2. Cancer Center, The Second Hospital, Cheeloo College of medicine Shandong University Jinan Shandong China

3. Department of Pharmacy, Shandong Provincial Third Hospital, Cheeloo College of Medicine Shandong University Jinan Shandong China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12828

Reference29 articles.

1. Ovarian cancer

2. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics

3. Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives

4. Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of S-phase kinase associated protein 2 stabilized tumor suppressors leading to apoptotic cell death in squamous skin cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3